What you need to remember Cramer saying, as I do because I recorded it when he said it on CNBC, is that TSLA is a great car, great car. Don't like the stock, like the car. Until someone makes a car like TSLA and does everything the TSLA does and costs less, TSLA is going to be the winner.
People crack me up! All this selling because of a downgrade by CLSA? Who the h**l is CLSA? I've never heard of them until this morning. So it doesn't matter that Stifel Nicolaus rated TSLA a buy w/a target of $400.00 on 03/24?, or that Pacific Crest said outperform w/a target of $293.00 on 3/23? The only thing that matters is what CLSA said today?? Really people??
I think it's because even though they missed the primary endpoint in this trial, they are still seeing positive data in other trials/phases.
Exactly. The ones that will be hurting are the ones that were charging WAY too much for oil to begin with. OPEC!!
I checked out flash ratings this morning and yesterday Zacks downgraded GWPH to Neutral with a price target of 82.50, but Cowens reiterated Outperform w/a target price of 110. Too funny.
That's exactly right, but their other product "Epidiolex," for epilepsy in children is doing very well. Look at the additional comment Cramer made under the headlines. Investors only cared about the bad and totally disregarded the good as this is a speculative stock.
The only reason this stock is tanking is because the ulcerative colitis thing did not go well. GWPH CEO said that their main focus is on Epidiolex, which is doing very well. Also, Sativex is sold in 27 countries. This company IS making money and has the potential to make a lot more. Don't listen to the A----LE shorts.
I just saw how they "reiterated," their outperform w/a target price of $110.00.